Cargando…
Nivolumab induced remitting seronegative symmetrical synovitis with pitting edema in a patient with melanoma: a case report
BACKGROUND: Novel immune checkpoint inhibitors have been often utilized for different types of malignancies as salvage therapy with varying success. One obstacle to immune checkpoint inhibitor use is the higher incidence of immune-mediated side effects that can prompt discontinuation of therapy. Rem...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6389137/ https://www.ncbi.nlm.nih.gov/pubmed/29478412 http://dx.doi.org/10.1186/s13256-018-1579-1 |